Adults with major depressive disorder experienced statistically significant and clinically meaningful improvements with a single dose of lysergide through 12 weeks, according to a press release from Definium Therapeutics.“Major depressive disorder and generalized anxiety disorder impose an enormous burden on patients, families and our society,” Robert Barrow, CEO of Definium Therapeutics, said during a webcast regarding the study. “And despite…
Source: Healio News
